European Journal of Medicinal Chemistry
Издатель: Elsevier · ISSN 0223-5234 · 57 статей
- Design, synthesis and biological evaluation of CYP1B1 targeted degraders for sensitizing immune checkpoint inhibitor therapy
- Targeting carbonic anhydrase IX to overcome hypoxia-driven resistance in glioblastoma
- Discovery of potent, selective, and orally bioavailable GluN2B-NMDA receptor antagonists for the treatment of depression
- Pharmacophore-based construction of spiro[indoline-3,4′-piperidine] ureas as dual-target MOR/TRPV1 lead agents for pain
- Design, synthesis and in vitro anti-tubercular evaluation of novel 5-heterocycle substituted-5, 6-dihydropyrido[2,3-d]pyrimidine-4, 7(3H, 8H)-dione compounds
- Targeting the DFG-out conformation of TTBK1 enables the discovery of selective type II neuroprotective inhibitors
- Structure-guided design and optimization of 3-amino-pyrazine-2-oxadiazole derivatives as novel FGFR2 inhibitors
- Discovery of the first orally bioavailable GLI1 PROTAC for the treatment of colorectal cancer
- Natural dehydrocostus lactone-based analogues as new structural PDPK1 allosteric activators against HBV
- Honeybee (Apis mellifera) venom and its bioactive peptides tertiapin and apamin modulate the proteome of SARS-CoV-2-infected cells
- Discovery of methylimidazolylethyl-pyrimidinamine derivatives as new glutaminyl cyclase inhibitors
- CODA-DTA: A context-guided model for predicting drug–target binding affinity in new compounds and targets
- Discovery and optimization of novel HDAC/proteasome dual inhibitors with antitumor activity in solid tumor models
- Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease
- Direct-to-biology high-throughput optimization enables rapid hit-to-lead discovery of potent CDK2 inhibitors
- First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells
- Green and scalable supercritical fluid chromatographic resolution of 5-nitroindoline derivatives: Enantiomer-specific biological evaluation and COX-2 inhibition insights
- Identification of Indostat as a selective HDAC6 inhibitor for reducing inflammatory stimuli triggered by a synthetic analogue of viral double-stranded RNA in hippocampal neurons
- Nitroimidazole containing cyclicpeptide [68Ga]Ga-ZJUIQB-G002 as a new FAP-targeting radionuclide tracer
- Azo-based prodrugs therapeutic systems: From microbial azoreducases and tumor reductases activation to medicinal chemistry perspectives
- Unraveling the anticancer potential of stilbenes: Structure, mechanisms, and formulation-based advances
- Amphiphilic dipeptide mimetics via N/C-terminal modulation: Discovery of potent antibacterial candidates against gram-positive pathogens
- Design, synthesis, and evaluation of covalent HER2-targeting tracers with increased tumor uptake and prolonged retention for cancer theranostics
- Discovery of biphenyl tetrazole derivatives as potent Keap1-Nrf2 protein-protein interaction inhibitors via structure-guided modification for the intervention of hypoxia-induced injury
- Discovery of isoindolinone derivatives as potent, safe, and intravenously administrable NaV1.8 inhibitors for the treatment of pain
- Optimization of 8-hydroxyquinolines as potent GLI1-targeting Hedgehog pathway inhibitors with anti-SHH medulloblastoma activity
- Discovery of multifunctional coumarin–benzylpiperidine hybrids combining acetylcholinesterase inhibition with attenuation of tau hyperphosphorylation for Alzheimer's disease